GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krebs Biochemicals & Industries Ltd-$

Krebs Biochemicals & Industries Ltd Q1 FY27 Unaudited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 06 Aug 2026, 01:50 PM IST  ·  BSE ID: 5c9ce52f-d7cd-40ba-978d-3bab12d89435
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has officially approved the financial numbers for the first three months of its current business year.
🤖 AI Summary
  • Krebs Biochemicals & Industries Ltd (KBIL) approved its unaudited financial results for the quarter ended June 30, 2026.
  • The Board of Directors took on record the Limited Review Report from auditors for the first quarter.
  • The Board meeting, held on August 6, 2026, started at 11:30 am and concluded at 01:30 p.m.
  • The company informed BSE and NSE as per Regulation 30 and 33 of SEBI (LODR) Regulations 2015.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are informed that the company has completed the regulatory step of approving its first quarter financial results for FY27.
🔍
Management Signal
The Board's approval of the unaudited financial results indicates adherence to regulatory timelines for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Release of the detailed unaudited financial results for Q1 FY27.
Any subsequent press releases or investor calls regarding Q1 FY27 performance.
Board meeting outcomes for Q2 FY27 results in the coming months.
LOW RISK The filing is a routine compliance update without new business or financial risks disclosed.
💡 Investor Takeaway
Krebs Biochemicals & Industries Ltd's Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026, and also took on record the Limited Review Report by the auditors. This filing confirms completion of a compliance requirement.
❓ Frequently Asked Questions
What event did Krebs Biochemicals & Industries Ltd announce on August 6, 2026?
Krebs Biochemicals & Industries Ltd announced the outcome of its Board Meeting, where the unaudited financial results for the 1st quarter ended June 30, 2026, were approved.
What was the duration of the Board Meeting for Krebs Biochemicals & Industries Ltd?
The Board Meeting of Krebs Biochemicals & Industries Ltd commenced at 11:30 am and concluded at 01:30 p.m. on August 6, 2026.
What regulatory compliance did Krebs Biochemicals & Industries Ltd fulfill with this filing?
Krebs Biochemicals & Industries Ltd fulfilled compliance under Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.